319-60-8 Usage
Uses
Used in Pharmaceutical Industry:
3,5-Difluoro-4-methoxybenzoic acid is used as an intermediate in the synthesis of pharmaceuticals for its antimicrobial and anti-inflammatory properties. It plays a crucial role in the development of new drugs that can effectively combat infections and reduce inflammation.
Used in Agrochemical Industry:
In the agrochemical industry, 3,5-Difluoro-4-methoxybenzoic acid is used as an intermediate in the synthesis of agrochemicals. Its antimicrobial properties make it a valuable component in the development of pesticides and other agricultural chemicals that protect crops from diseases and pests.
Used in Organic Synthesis:
3,5-Difluoro-4-methoxybenzoic acid is used as a building block in organic synthesis. Its unique structure allows for the creation of various compounds with different properties and applications, making it a valuable component in the development of new chemical entities for various industries.
Used in Drug Development:
Due to its antimicrobial and anti-inflammatory properties, 3,5-Difluoro-4-methoxybenzoic acid is a potential candidate for drug development. Researchers can use 3,5-Difluoro-4-methoxybenzoic acid as a starting point to design and synthesize new drugs that target specific diseases and conditions, offering novel treatment options for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 319-60-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,1 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 319-60:
(5*3)+(4*1)+(3*9)+(2*6)+(1*0)=58
58 % 10 = 8
So 319-60-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H6F2O3/c1-13-7-5(9)2-4(8(11)12)3-6(7)10/h2-3H,1H3,(H,11,12)
319-60-8Relevant articles and documents
PLANT DISEASE CONTROL AGENT, AND PLANT DISEASE CONTROL METHOD
-
Page/Page column 49, (2010/05/13)
Disclosed is a plant disease control agent comprising an amide compound represented by the formula (1) as an active ingredient. (1): wherein X1 represents a fluorine atom or a methoxy group; X2 represents a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C1-C4 haloalkyl group, a C1-C4 alkoxy group, a C1-C4 alkylthio group, a C1-C4 hydroxyalkyl group and so on; Z1 represents an oxygen atom or a sulfur atom; A1 represents a single bond, -CH2- and so on; and G1 represents a group CR6R7R8, a C3-6 cycloalkyl group and so on.
PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE
-
Page/Page column 46, (2008/12/07)
The invention relates toa pharmaceutical composition comprising a pyrazole-O-glucoside derivative selected from the group of compounds (1) to (29) according to claim 1 in combination with at least one second therapeutic agent which is suitable in the trea
METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES
-
Page/Page column 32; 33, (2010/11/25)
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for
Triazole derivatives
-
, (2011/03/17)
The present invention relates to triazole and imidazole derivatives of formula I and to their pharmaceutically acceptable acid addition salts. These compounds are NMDA receptor subtype blockers and are useful for the treatment of diseases related to the NMDA receptor.